ZONNIC Nicotine Replacement Therapy Trademark Application
Summary
The USPTO received trademark application TM98935361 for ZONNIC covering pharmaceutical preparations for nicotine replacement therapy and smoking cessation products. The application was filed on January 3, 2025, under Intent to Use provisions, covering goods including tablets, lozenges, patches, gums, sprays, and pouches containing nicotine for medical purposes.
What changed
The USPTO published trademark application TM98935361 for ZONNIC, covering Class 5 pharmaceutical preparations for suppressing smoking, treating nicotine addiction, and nicotine replacement therapy products. The goods include medicated tablets, lozenges, patches, chewing gum, mouth sprays, and pouches. The application was filed as Intent to Use, indicating the applicant plans to use the mark in commerce but has not yet done so.
Pharmaceutical companies and drug manufacturers offering smoking cessation products should review this application for potential conflicts with existing marks. Trademark applicants have no immediate action required; the application will proceed through examination, publication for opposition, and either registration or abandonment. No compliance deadlines, penalties, or regulatory requirements arise from this trademark filing.
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
ZONNIC
Intent to Use TM98935361 Kind: intenttouse Mar 31, 2026
Abstract
Pharmaceutical preparations for suppressing, reducing, eliminating smoking and the urge to smoke; Pharmaceutical preparations for treating drug and alcohol abuse and addiction; Pharmaceutical preparations for treating nicotine addiction; Pharmaceutical preparations for nicotine replacement therapy; Pharmaceutical preparations in tablet, in lozenge form for suppressing, reducing, eliminating smoking and the urge to smoke; medicated preparations and substances for suppressing, reducing, eliminating smoking and the urge to smoke; Patches for medical purposes, namely nicotine patches for use as aids to stop smoking; Chewing gum for suppressing, reducing, eliminating smoking and the urge to smoke; Nicotine mouth sprays for medical purposes; Pouches, chewing gum, lozenges, tablets and patches containing nicotine to aid in smoking cessation.
Filing Date
2025-01-03
Named provisions
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.